Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Application of a Thermosensitive In Situ Gel of Chitosan-Based Nasal Spray Loaded with Tranexamic Acid for Localised Treatment of Nasal Wounds.

Gholizadeh H, Messerotti E, Pozzoli M, Cheng S, Traini D, Young P, Kourmatzis A, Caramella C, Ong HX.

AAPS PharmSciTech. 2019 Sep 3;20(7):299. doi: 10.1208/s12249-019-1517-6.

PMID:
31482286
2.

Co-Spray-Dried Urea Cross-Linked Hyaluronic Acid and Sodium Ascorbyl Phosphate as Novel Inhalable Dry Powder Formulation.

Fallacara A, Busato L, Pozzoli M, Ghadiri M, Ong HX, Young PM, Manfredini S, Traini D.

J Pharm Sci. 2019 Sep;108(9):2964-2971. doi: 10.1016/j.xphs.2019.04.015. Epub 2019 Apr 19.

PMID:
31009614
3.

Smart thermosensitive chitosan hydrogel for nasal delivery of ibuprofen to treat neurological disorders.

Gholizadeh H, Cheng S, Pozzoli M, Messerotti E, Traini D, Young P, Kourmatzis A, Ong HX.

Expert Opin Drug Deliv. 2019 Apr;16(4):453-466. doi: 10.1080/17425247.2019.1597051. Epub 2019 Apr 3.

PMID:
30884987
4.

In vitro characterization of physico-chemical properties, cytotoxicity, bioactivity of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate nasal powder formulation.

Fallacara A, Busato L, Pozzoli M, Ghadiri M, Ong HX, Young PM, Manfredini S, Traini D.

Int J Pharm. 2019 Mar 10;558:341-350. doi: 10.1016/j.ijpharm.2019.01.012. Epub 2019 Jan 16.

PMID:
30659923
5.

Formulation and Characterization of Native and Crosslinked Hyaluronic Acid Microspheres for Dermal Delivery of Sodium Ascorbyl Phosphate: A Comparative Study.

Fallacara A, Marchetti F, Pozzoli M, Citernesi UR, Manfredini S, Vertuani AS.

Pharmaceutics. 2018 Dec 1;10(4). pii: E254. doi: 10.3390/pharmaceutics10040254.

6.

Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives.

Garrastazu Pereira G, Rawling T, Pozzoli M, Pazderka C, Chen Y, Dunstan CR, Murray M, Sonvico F.

Nanomaterials (Basel). 2018 Oct 13;8(10). pii: E825. doi: 10.3390/nano8100825.

7.

Combination of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate for the treatment of inflammatory lung diseases: An in vitro study.

Fallacara A, Busato L, Pozzoli M, Ghadiri M, Ong HX, Young PM, Manfredini S, Traini D.

Eur J Pharm Sci. 2018 Jul 30;120:96-106. doi: 10.1016/j.ejps.2018.04.042. Epub 2018 Apr 30.

PMID:
29723596
8.

Development of a Soluplus budesonide freeze-dried powder for nasal drug delivery.

Pozzoli M, Traini D, Young PM, Sukkar MB, Sonvico F.

Drug Dev Ind Pharm. 2017 Sep;43(9):1510-1518. doi: 10.1080/03639045.2017.1321659. Epub 2017 May 7.

PMID:
28425305
9.

The nasal delivery of nanoencapsulated statins - an approach for brain delivery.

Clementino A, Batger M, Garrastazu G, Pozzoli M, Del Favero E, Rondelli V, Gutfilen B, Barboza T, Sukkar MB, Souza SA, Cantù L, Sonvico F.

Int J Nanomedicine. 2016 Dec 7;11:6575-6590. eCollection 2016.

10.

Resveratrol solid lipid microparticles as dry powder formulation for nasal delivery, characterization and in vitro deposition study.

Martignoni I, Trotta V, Lee WH, Loo CY, Pozzoli M, Young PM, Scalia S, Traini D.

J Microencapsul. 2016 Dec;33(8):735-742. doi: 10.1080/02652048.2016.1260659. Epub 2016 Nov 28.

PMID:
27841060
11.

Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products.

Pozzoli M, Ong HX, Morgan L, Sukkar M, Traini D, Young PM, Sonvico F.

Eur J Pharm Biopharm. 2016 Oct;107:223-33. doi: 10.1016/j.ejpb.2016.07.010. Epub 2016 Jul 11.

PMID:
27418393
12.

Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation.

Pozzoli M, Rogueda P, Zhu B, Smith T, Young PM, Traini D, Sonvico F.

Drug Dev Ind Pharm. 2016 Oct;42(10):1660-8. doi: 10.3109/03639045.2016.1160110. Epub 2016 Mar 22.

PMID:
26953090
13.

Opportunities and challenges for the nasal administration of nanoemulsions.

Comfort C, Garrastazu G, Pozzoli M, Sonvico F.

Curr Top Med Chem. 2015;15(4):356-68. Review.

PMID:
25579345

Supplemental Content

Loading ...
Support Center